Anna-Maria Larsson

801 total citations · 2 hit papers
10 papers, 463 citations indexed

About

Anna-Maria Larsson is a scholar working on Oncology, Cancer Research and Artificial Intelligence. According to data from OpenAlex, Anna-Maria Larsson has authored 10 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Cancer Research and 2 papers in Artificial Intelligence. Recurrent topics in Anna-Maria Larsson's work include Radiomics and Machine Learning in Medical Imaging (2 papers), Erythropoietin and Anemia Treatment (2 papers) and Global Cancer Incidence and Screening (2 papers). Anna-Maria Larsson is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (2 papers), Erythropoietin and Anemia Treatment (2 papers) and Global Cancer Incidence and Screening (2 papers). Anna-Maria Larsson collaborates with scholars based in Sweden, Israel and Norway. Anna-Maria Larsson's co-authors include Aldana Rosso, Hanna Sartor, Solveig Hofvind, Ingvar Andersson, Kristina Lång, Stefan Larsson, Charlotte Högberg, Lisa Rydén, Kristina Aaltonen and Caroline Bergenfelz and has published in prestigious journals such as PLoS ONE, Cancer Research and The Lancet Oncology.

In The Last Decade

Anna-Maria Larsson

9 papers receiving 459 citations

Hit Papers

Artificial intelligence-supported screen reading versus s... 2023 2026 2024 2025 2023 2025 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
    2023 237 citations Kristina Lång, Anna-Maria Larsson et al. The Lancet Oncology profile →
  2. Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
    2025 35 citations Hanna Sartor, David Schmidt et al. The Lancet Digital Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna-Maria Larsson Sweden 8 167 162 155 121 98 10 463
Sara Romero-Martín Spain 6 152 0.9× 80 0.5× 177 1.1× 63 0.5× 50 0.5× 10 361
Saba Shafi United States 10 126 0.8× 135 0.8× 123 0.8× 50 0.4× 49 0.5× 42 387
Vidya Sankar Viswanathan United States 10 179 1.1× 101 0.6× 91 0.6× 37 0.3× 14 0.1× 39 307
Liren Jiang China 10 106 0.6× 106 0.7× 60 0.4× 14 0.1× 20 0.2× 25 307
Si-Cong Ma China 9 150 0.9× 190 1.2× 96 0.6× 31 0.3× 36 0.4× 21 391
Felipe Batalini United States 11 71 0.4× 186 1.1× 49 0.3× 48 0.4× 10 0.1× 39 411
Damian Rieke Germany 11 63 0.4× 95 0.6× 107 0.7× 90 0.7× 14 0.1× 42 402
Sophie Chheang United States 5 87 0.5× 43 0.3× 45 0.3× 78 0.6× 18 0.2× 7 264
Bernadette Redd United States 8 133 0.8× 163 1.0× 50 0.3× 21 0.2× 54 0.6× 24 366
Tomohiro Kikuchi Japan 10 59 0.4× 170 1.0× 20 0.1× 52 0.4× 121 1.2× 54 443

Countries citing papers authored by Anna-Maria Larsson

Since Specialization
Citations

This map shows the geographic impact of Anna-Maria Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna-Maria Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna-Maria Larsson more than expected).

Fields of papers citing papers by Anna-Maria Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna-Maria Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna-Maria Larsson. The network helps show where Anna-Maria Larsson may publish in the future.

Co-authorship network of co-authors of Anna-Maria Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna-Maria Larsson. A scholar is included among the top collaborators of Anna-Maria Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna-Maria Larsson. Anna-Maria Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sartor, Hanna, David Schmidt, Anna-Maria Larsson, et al.. (2025). Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study. The Lancet Digital Health. 7(3). e175–e183. 35 indexed citations breakdown →
2.
Sartor, Hanna, et al.. (2024). Mammographic features differ with body composition in women with breast cancer. European Radiology. 35(1). 151–159.
3.
4.
Lång, Kristina, Anna-Maria Larsson, Stefan Larsson, et al.. (2023). Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. The Lancet Oncology. 24(8). 936–944. 237 indexed citations breakdown →
5.
Bendahl, Pär‐Ola, Kristina Aaltonen, Mårten Fernö, et al.. (2020). The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast—Long-Term Prognostic Significance. Cells. 9(7). 1718–1718. 11 indexed citations
6.
Welinder, Charlotte, et al.. (2015). A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation. Journal of Translational Medicine. 13(1). 126–126. 22 indexed citations
7.
Bergenfelz, Caroline, Anna-Maria Larsson, Kristoffer von Stedingk, et al.. (2015). Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients. PLoS ONE. 10(5). e0127028–e0127028. 115 indexed citations
8.
Larsson, Anna-Maria, Caroline Wigerup, Jianmin Sun, et al.. (2014). EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation. Biochemical and Biophysical Research Communications. 445(1). 163–169. 17 indexed citations
9.
Larsson, Anna-Maria, Caroline Wigerup, Jianmin Sun, et al.. (2014). Abstract 3464: The effect of EPO-receptor in estrogen receptor positive breast cancer. Cancer Research. 74(19_Supplement). 3464–3464. 1 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Romero-Martín Breakdown of academic impact, for papers by Saba Shafi Breakdown of academic impact, for papers by Vidya Sankar Viswanathan Breakdown of academic impact, for papers by Liren Jiang Breakdown of academic impact, for papers by Si-Cong Ma Breakdown of academic impact, for papers by Felipe Batalini Breakdown of academic impact, for papers by Damian Rieke Breakdown of academic impact, for papers by Sophie Chheang Breakdown of academic impact, for papers by Bernadette Redd Breakdown of academic impact, for papers by Tomohiro Kikuchi
Rankless by CCL
2026